ResourceSpectroscopy

Managing the risk of nitrosamines in medicinal drugs

6 Apr 2022

Nitrosamines, also known as N-nitrosamines, refer to any molecule with a nitroso functional group (NO⁺) bonded to a deprotonated amine. Nitrosamine impurities are of particular concern as there is evidence that they can be carcinogenic, and therefore their presence in medicines is considered unacceptable.

In this free eBook, discover a range of ultra-fast mass spectrometry technologies for the quantification of trace levels of nitrosamine impurities from various drug substances, drug products, and solvents.

This eBook will also cover:

  • Sartan analysis
  • Metformin analysis
  • Other API analyses
  • Residual solvent analysis

Q-TOF LCMS-9030

Shimadzu Corporation

Offering effortless Q-TOF LCMS performance, the LCMS-9030 allows users to perform critical qualitative and quantitative analysis with genuine confidence and ease.

(8)

Links

Tags